Marshall Wace’s Collegium Pharmaceutical COLL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.04M | Buy |
+136,721
| New | +$4.04M | ﹤0.01% | 1151 |
|
|
2024
Q3 | – | Sell |
-70,964
| Closed | -$2.29M | – | 2361 |
|
|
2024
Q2 | $2.29M | Buy |
+70,964
| New | +$2.29M | ﹤0.01% | 1191 |
|
|
2024
Q1 | – | Sell |
-136,049
| Closed | -$4.19M | – | 2180 |
|
|
2023
Q4 | $4.19M | Sell |
136,049
-250,247
| -65% | -$7.7M | 0.01% | 802 |
|
|
2023
Q3 | $8.63M | Sell |
386,296
-108,180
| -22% | -$2.42M | 0.02% | 629 |
|
|
2023
Q2 | $10.6M | Sell |
494,476
-85,435
| -15% | -$1.84M | 0.02% | 617 |
|
|
2023
Q1 | $13.9M | Buy |
579,911
+272,881
| +89% | +$6.55M | 0.03% | 512 |
|
|
2022
Q4 | $7.12M | Buy |
307,030
+267,065
| +668% | +$6.2M | 0.02% | 870 |
|
|
2022
Q3 | $640K | Buy |
+39,965
| New | +$640K | ﹤0.01% | 1963 |
|
|
2021
Q3 | – | Sell |
-11,718
| Closed | -$277K | – | 2456 |
|
|
2021
Q2 | $277K | Buy |
+11,718
| New | +$277K | ﹤0.01% | 1853 |
|
|
2019
Q2 | – | Sell |
-56,961
| Closed | -$862K | – | 1384 |
|
|
2019
Q1 | $862K | Buy |
+56,961
| New | +$862K | 0.01% | 973 |
|